Riskpilot← Back to searchSign inGet full accessKabissa AB
ABActiveOrg 5567769368Ceresgatan 7 BMedical specialists activities · NACE 8622Est. 20092 employees
Revenue 2024
SEK 81K
-3% vs 2023
EBITDA margin
32.5%
+219% vs 2023
Equity ratio
55.6%
Financial strength
Net profit 2024
SEK 26K
+219% vs 2023
| Revenue | SEK 81K | -3% |
| EBITDA | SEK 26K | +219% |
| Net profit | SEK 26K | +219% |
| Total assets | SEK 121K | +24% |
| Equity | SEK 67K | +64% |
| Employees | 2 | — |
Legal name
Kabissa AB
Org number
5567769368
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
28 januari 2009
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Bolaget skall bedriva specialistläkarverksamhet inom öppenvård, utbildning inom sjukvård, äga och förvalta fast och lös egendom samt därmed förenlig verksamhet. Bolaget ska dessutom bedriva design och produktutveckling samt försäljning inom områdena hygienprodukter, hushållsprodukter och accessoarer samt därmed förenlig verksamhet.
Address
Ceresgatan 7 B
Email
daniel.strath@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 35 | 47 | 76 | 83 | 81 |
| Staff expenses | — | — | −0 | — | — |
| EBITDA | 19 | −12 | −9 | −22 | 26 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 19 | −12 | −9 | −22 | 26 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | 19 | −12 | −9 | −22 | 26 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 19 | −12 | −9 | −22 | 26 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 115 | 124 | 113 | 98 | 121 |
| Equity | 84 | 72 | 63 | 41 | 67 |
| Long-term debt | 11 | 23 | 23 | 23 | 23 |
| Short-term debt | 20 | 29 | 27 | 33 | 31 |
| Total debt | 31 | 52 | 50 | 57 | 54 |
EBITDA margin
32.5%
This company
15.8%
Market median
+106% vs market
20202024
Equity ratio
55.6%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
38.9%
This company
18.4%
Market median
+111% vs market
20202024
Net profit margin
32.5%
This company
8.1%
Market median
+301% vs market
20202024
Asset turnover
0.66×
This company
1.12×
Market median
-41% vs market
20202024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kabissa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Ingrid Maria Margareta Stråth | Board of Directors | 0 companies |
| Gunilla Eva Margareta Stråth | Deputy Board Member | 0 companies |
| Gunilla Eva Margareta Stråth | Deputy Board Member | 0 companies |
| Albin Hugo Stråth | Board of Directors | 0 companies |
| Anna Ingrid Maria Margareta Stråth | Board of Directors | 0 companies |
| Erik Daniel Stråth | Chairman | 0 companies |